Literature DB >> 9579188

Leiomyosarcoma of the maxillary sinus: CT and MRI findings.

H Tanaka1, P L Westesson, D C Wilbur.   

Abstract

This report describes the CT and MRI appearances of a leiomyosarcoma of the maxillary sinus. CT showed frank bony destruction, no calcification and a low attenuation area within the mass. MRI showed intermediate intensity on T1 weighted images, intermediate to slightly high signal intensity on T2 weighted images and moderate inhomogeneous enhancement. Precise identification of the extent of the tumour, especially of orbital invasion, is of utmost importance because local recurrence is common after the resection of leiomyosarcomas.

Entities:  

Mesh:

Year:  1998        PMID: 9579188     DOI: 10.1259/bjr.71.842.9579188

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  5 in total

1.  Leiomyosarcoma of the maxilla in a 24-year-old man who initially presented with odontalgia, and suffered from tumour mismanagement.

Authors:  Shokouh Taghipour Zahir; Naser Sefidrokh Sharahjin
Journal:  BMJ Case Rep       Date:  2013-12-05

Review 2.  Leiomyosarcoma of the Nasal Cavity and Paranasal Sinuses: A Case Report and Comprehensive Review of the Literature.

Authors:  Sumita S Sam; Brian Stewart; Elham Nasri; Marino E Leon; Ernesto Martinez Duarte
Journal:  Head Neck Pathol       Date:  2022-02-14

3.  MRI characterization of inflammatory myofibroblastic tumors in the maxillofacial region.

Authors:  Hui Li; De Ling Wang; Xue Wen Liu; Zhi Jun Geng; Chuan Miao Xie
Journal:  Diagn Interv Radiol       Date:  2014 Jul-Aug       Impact factor: 2.630

4.  Leiomyosarcoma: a rare sinonasal malignancy.

Authors:  Matthew Ming Kei Kwok; Stewart Lee; Patrick Hosking
Journal:  BMJ Case Rep       Date:  2018-03-27

Review 5.  Rare Diseases of the Nose, the Paranasal Sinuses, and the Anterior Skull Base.

Authors:  Fabian Sommer
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.